Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Anadarko Petroleum Corporation ( APC - Analyst Report ) , one of the largest independent oil and natural gas exploration and production (E&P) companies of the world, is set to post its third-quarter 2012 financial results after the market bell on October 29, 2012.
Recap, Second Quarter-2012
Anadarko reported adjusted net income per share of 85 cents, beating the Zacks Consensus Estimate of 77 cents per share but falling short of the year-ago earnings of $1.14 per share.
Revenue reported in the said quarter witnessed a 12.2% decline to $3.22 billion from $3.67 million in the prior-ago quarter. Revenue also trailed the Zacks Consensus Estimate of $3.42 billion.
The top-line lag was due to a 45.3% and 23.8% slash in natural gas and natural gas liquid sales from the year-earlier period.
Guidance 2012
Anadarko revised its 2012 sales expectation by 3 million barrels to 261–265 million barrels of oil equivalent (“MMBOE”) from the prior range of 258–262 MMBOE. The third quarter sales volume is expected to be in the range of 65-67 MMBOE.
Capital investment target of the company for the third quarter and full year 2012 is expected to be in the range of $1.65–$1.8 billion and $6.6–$6.9 billion, respectively
Zacks Consensus
The Zacks Consensus Estimate for the third quarter 2012 is 76 cents per share, higher than the earnings of 65 cents reported in the comparable year-ago quarter. At present, the Zacks Consensus Estimate for earnings ranges from 61 cents per share to $1.09 per share.
For 2012, the Zacks Consensus Estimate is $3.51 per share, up 3.7% from $3.38 per share registered in the earlier year. The current Zacks Consensus Estimate ranges between $3.03 per share and $4.19 per share.
Estimate Revision Trend
Agreement
We observe significant estimate revisions at this point. For third quarter 2012, among a total of 24 estimates, 3 inched upwards and 7 estimates went up in the last 7 days and 30 days, respectively. Conversely, 1 lone estimate stooped down in the last 7 days and 9 estimates moved south in the past month.
For 2012, out of 22 estimates, 2 and 8 trended up in the last week and month, respectively, whereas 1 and 6 estimates slithered down in the past 7 and 30 days, respectively.
Magnitude
The Zacks Consensus Estimate for the third quarter increased by a penny for the past week. Also, the estimate increased by 2 cents to 76 cents from 74 cents in the last 30 days. For 2012, the consensus estimate notched up by 4 cents to $3.51 from $3.47 and by 2 cents to $3.51 from $3.49 in the past month and week, respectively.
Surprise History
With respect to earnings surprise, the company’s performance was strong in three of the last four quarters and missed the estimates in the third quarter of 2011. The earnings surprise in the last four quarters ranged from (1.5%) to 41.7%. The average surprise over the last four quarters remained a positive 15.4%.
Our Recommendation
Anadarko’s significant natural gas and oil discoveries in Africa and also monetization of a portion of its stake in the Salt Creek field in Wyoming and the Lucius development project in the Gulf of Mexico will accentuate the future growth prospects of the company. The company’s ambitious capital program of $7.0 billion to $7.4 billion for 2012 will also boost exploration goals.
However, we expect generic risks related to unexpected outages or rig accidents, a sluggish US macro environment and commodity price volatilities on a continuous basis will threaten the company’s financials.
Anadarko operates in a highly competitive energy market and faces stiff competition from companies like ConocoPhilips ( COP - Analyst Report ) and BP plc ( BP - Analyst Report ) .
Currently, we are maintaining a long-term Neutral recommendation on Anadarko Petroleum Corp. The company has a Zacks #3 Rank implying a short-term Hold rating on the stock.
Read the full reports :
Analyst Report on APC
Analyst Report on BP
Analyst Report on COP